References
- Nishie W, Sawamura D, Goto M et al. Humanuzation of autoantigen. Nat. Med.13, 378–383 (2007).
- Liu Z. Bullous pemphigoid: using animal models to study the immunopathology. J. Investig. Dermatol. Symp. Proc.9, 41–46 (2004).
- Schimdt E, Reimer S, Kruse N et al. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured keratinocytes. J. Invest. Dermatol.115, 842–848 (2000).
- Sitaru C, Schmidt E, Petermann S, Munteanu LS, Brocker EB, Zillikens D. Autoantibodies to bullous pemphigoid antigen 180 induce dermal–epidermal separation in cryosections of human skin. J. Invest. Dermatol.118, 664–671 (2002).
- Liu Z, Diaz LA, Troy JL et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J. Clin. Invest.92, 2480–2488 (1993).
- Nelson KC, Zhao M, Schroeder PR et al. Role of different pathways of the complement cascade in experimental bullous pemphigoid. J. Clin. Invest.116, 2892–2900 (2006).
- Liu Z, Li N, Diaz LA, Shipley M, Senior RM, Werb Z. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. J. Clin. Invest.115, 879–887 (2005).
- Jiang QJ, Uitto J. Animal models of epidermolysis bullosa – targets for gene therapy. J. Invest. Dermatol.124, xi–xiii (2005).
- Hertl M, Eming R, Veldman C. T cell control in autoimmune bullous skin disorders. J. Clin. Invest.116, 1159–1166 (2006).